Stockscreener 앱 받기
3.84
2.04%
-0.08
전일 마감가:
$3.92
열려 있는:
$3.96
하루 거래량:
453.81K
Relative Volume:
1.15
시가총액:
$225.42M
수익:
$17.63M
순이익/손실:
$-57.71M
주가수익비율:
-2.5946
EPS:
-1.48
순현금흐름:
$-60.45M
1주 성능:
-2.78%
1개월 성능:
+16.72%
6개월 성능:
+13.27%
1년 성능:
-4.95%
1일 변동 폭
$3.76
$4.0041
1주일 범위
$3.76
$4.165
52주 변동 폭
$1.94
$5.65
Scpharmaceuticals Inc Stock (SCPH) Company Profile
명칭
Scpharmaceuticals Inc
전화
617-517-0730
주소
25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON, MA
SCPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SCPH
Scpharmaceuticals Inc
|
3.84 | 225.42M | 17.63M | -57.71M | -60.45M | -1.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
440.87 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
509.72 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
309.70 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
542.15 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
247.08 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Scpharmaceuticals Inc Stock (SCPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-07 | 개시 | Craig Hallum | Buy |
| 2022-12-01 | 개시 | Cowen | Outperform |
| 2022-10-21 | 재개 | Jefferies | Buy |
| 2022-10-11 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-02 | 개시 | Maxim Group | Buy |
| 2021-09-09 | 개시 | SVB Leerink | Mkt Perform |
| 2019-10-15 | 개시 | H.C. Wainwright | Buy |
| 2019-01-30 | 다운그레이드 | Leerink Partners | Outperform → Mkt Perform |
모두보기
Scpharmaceuticals Inc 주식(SCPH)의 최신 뉴스
Bank of America Corp DE Buys 3,647 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
With 42% stake, scPharmaceuticals Inc. (NASDAQ:SCPH) seems to have captured institutional investors' interest - Yahoo Finance
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Sold by Millennium Management LLC - Defense World
scPharmaceuticals Holds Annual Stockholders Meeting June 2025 - TipRanks
Jane Street Group LLC Raises Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Nuveen Asset Management LLC Has $320,000 Position in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
ProShare Advisors LLC Makes New Investment in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
ScPharmaceuticals targets CKD launch and rising Medicare fill rates to accelerate FUROSCIX growth trajectory - MSN
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Raises Stock Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Further Upside For scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Could Introduce Price Risks After 40% Bounce - simplywall.st
Deutsche Bank AG Raises Stake in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Northern Trust Corp Grows Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Wearable Injector Market Is Booming So Rapidly 2025-2032 - openPR.com
BNP Paribas Financial Markets Increases Stake in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Shareholders Will Likely Find scPharmaceuticals Inc.'s (NASDAQ:SCPH) CEO Compensation Acceptable - simplywall.st
Captrust Financial Advisors Acquires 21,523 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025 - Seeking Alpha
Price T Rowe Associates Inc. MD Buys Shares of 15,143 scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Purchased by Comerica Bank - Defense World
Leerink Partnrs Analysts Lower Earnings Estimates for SCPH - Defense World
What is HC Wainwright’s Estimate for SCPH Q1 Earnings? - Defense World
What is Leerink Partnrs’ Forecast for SCPH FY2027 Earnings? - Defense World
scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2025 Earnings Call Transcript - Insider Monkey
Market Sentiment Around Loss-Making scPharmaceuticals Inc. (NASDAQ:SCPH) - simplywall.st
scPharmaceuticals First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
scPharmaceuticals Earnings Call Highlights Growth and Expansion - TipRanks
ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates - MSN
ScPharmaceuticals Doubles FUROSCIX Sales In Q1, Launches In CKD, Eyes Autoinjector Filing In Q3 - Nasdaq
scPharmaceuticals Inc (SCPH) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion - Yahoo
scPharmaceuticals Inc (SCPH) Q1 2025 Earnings Call Highlights: R - GuruFocus
scPharmaceuticals Reports Strong Q1 2025 Growth - TipRanks
SCPH Reports Revenue Growth and Positive Outlook for FUROSCIX | - GuruFocus
Earnings call transcript: SC Pharmaceuticals Q1 2025 results miss forecast By Investing.com - Investing.com South Africa
Earnings call transcript: SC Pharmaceuticals Q1 2025 results miss forecast - Investing.com
scPharmaceuticals Inc Reports Q1 2025 Revenue of $11.8 Million, Exceeding Estimates; EPS Details Not Provided - GuruFocus
scPharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
SCPH Reports Revenue Growth and Positive Outlook for FUROSCIX | SCPH Stock News - GuruFocus
scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Wells Fargo & Company MN Purchases 9,663 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Insights Ahead: scPharmaceuticals's Quarterly Earnings - Nasdaq
scPharmaceuticals Inc (SCPH) Q1 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
scPharmaceuticals Inc (SCPH) Q1 2025: Everything You Need To Kno - GuruFocus
Barclays PLC Buys 24,717 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
scPharmaceuticals (SCPH) Expected to Announce Earnings on Tuesday - Defense World
89,690 Shares in scPharmaceuticals Inc. (NASDAQ:SCPH) Bought by Raymond James Financial Inc. - Defense World
scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025 - The Manila Times
Invesco Ltd. Purchases 6,073 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
JPMorgan Chase & Co. Raises Position in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences - The Manila Times
Scpharmaceuticals Inc (SCPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Scpharmaceuticals Inc 주식 (SCPH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% Owner |
Aug 13 '24 |
Buy |
4.00 |
500,000 |
2,000,000 |
5,806,670 |
| Nokes Rachael | CFO and Treasurer |
Aug 06 '24 |
Option Exercise |
0.00 |
10,445 |
0 |
72,851 |
1.86%
1.98%
자본화:
|
볼륨(24시간):